[Federal Register: June 27, 2002 (Volume 67, Number 124)]
[Notices]               
[Page 43344]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jn02-114]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 28, 2001, and published in the Federal 
Register on March 18, 2002, (67 FR 12049), Mallinckrodt, Inc., 
Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Difenoxin (9168)...........................  I
Morphine-N-oxide (9307)....................  I
Normorphine (9313).........................  I
Norlevorphanol (9634)......................  I
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture the controlled substances as 
analytical reference standards to be utilized internally and for sale 
to other companies.
    No comments or objections were received. DEA has considered the 
factors in Title 21, United States Code, Section 823(a) and determined 
that the registration of Mallinckrodt, Inc. to manufacture listed 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Mallainckrodt, Inc. on a regular basis to 
ensure that the company's continued registration is consistent with the 
public interest. These investigations have included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
classes of the controlled substances listed above is granted.

    Dated: June 14, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-16287 Filed 6-26-02; 8:45 am]
BILLING CODE 4410-09-M